Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Regulatory T cells (Tregs) are a specialized subpopulation of T lymphocytes that play a critical role in modulating the immune system. They maintain tolerance to self-antigens, prevent autoimmune disease, and suppress excessive or misdirected immune responses.
Tregs employ several mechanisms to exert their immunosuppressive effects: 1. Inhibitory Cytokines: Secretion of cytokines such as IL‑10, TGF‑β which dampen effector cell activity. 2. Cytolysis: Direct killing of target cells via granzyme/perforin pathways. 3. Metabolic Disruption: High-affinity consumption of IL‑2 deprives other lymphocytes; expression of enzymes like CD39/CD73 generates adenosine which inhibits effector functions through A2A receptors. 4. Modulation of Antigen-Presenting Cells: Alter dendritic cell maturation/function via CTLA‑4-mediated interactions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Regulatory T-cell (Treg).